Alkem Laboratories Ltd.
|BSE: 539523||Sector: Health care|
|NSE: ALKEM||ISIN Code: INE540L01014|
|BSE 00:00 | 30 Oct||2634.25||
|NSE 00:00 | 30 Oct||2634.30||
|Mkt Cap.(Rs cr)||31,492|
|Mkt Cap.(Rs cr)||31492.46|
Alkem Laboratories Ltd. (ALKEM) - Latest News & Headlines
12.56 am | 23 Sep 2020 | Business Standard
Higher chronic sales, US market could offset some of the weakness in sales growth
6.09 pm | 7 Aug 2020 | Press Trust of India
Consolidated revenue from operations of the company stood at Rs 2,003.49 crore for the quarter under consideration. It was Rs 1,849.50 crore for the s...
10.42 am | 6 Aug 2020 | Business Standard
Alkem Laboratories has launched Favipiravir under the brand name 'Alfluenza' in India for the management of mild to moderate cases of Covid-19
10.13 pm | 14 May 2020 | Business Standard
Data from market research firm AIOCD-AWACS shows that sales of oseltamivir (common brand Tamiflu), used against the influenza virus and also for swine...
10.01 pm | 13 May 2020 | Business Standard
Lack of fresh prescriptions drags growth in acute therapies